Tomohisa Yamamoto Selected Research

Active Hexose Correlated Compound

2/2022	Efficacy of active hexose correlated compound on survival of patients with resectable/borderline resectable pancreatic cancer: a study protocol for a double-blind randomized phase II study.
11/2021	Nutritional impact of active hexose-correlated compound for patients with resectable or borderline-resectable pancreatic cancer treated with neoadjuvant therapy.
1/2016	Alleviating Effect of Active Hexose Correlated Compound (AHCC) on Chemotherapy-Related Adverse Events in Patients with Unresectable Pancreatic Ductal Adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomohisa Yamamoto Research Topics

Disease

21	Adenocarcinoma 06/2022 - 04/2012
15	Pancreatic Neoplasms (Pancreatic Cancer) 02/2022 - 12/2007
13	Neoplasms (Cancer) 06/2022 - 04/2011
8	Neoplasm Metastasis (Metastasis) 03/2022 - 04/2011
7	Pancreatic Fistula (Pancreatic Fistulas) 01/2019 - 08/2008
6	Lymphatic Metastasis 06/2022 - 04/2012
3	Cholangitis 11/2022 - 01/2014
3	Cholelithiasis 01/2020 - 01/2019
2	Ascites 06/2022 - 01/2017
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2021 - 01/2018
2	Diarrhea 01/2021 - 01/2017
2	Non-alcoholic Fatty Liver Disease 03/2016 - 03/2014
1	Pathologic Constriction (Stenosis) 11/2022
1	Malnutrition (Nutritional Deficiencies) 02/2022
1	Actinomycosis 08/2021
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 08/2021
1	Diabetes Mellitus 08/2021
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021
1	Hemorrhage 10/2020
1	Cholecystolithiasis 01/2020
1	Gallbladder Diseases (Gall Bladder Disease) 04/2019
1	Acute Cholecystitis 04/2019
1	Pancreatitis 04/2019
1	Edema (Dropsy) 04/2019
1	Carcinoma (Carcinomatosis) 04/2019
1	Gallbladder Neoplasms (Gallbladder Cancer) 01/2019
1	Neuroinflammatory Diseases 01/2019
1	Postoperative Cognitive Complications 01/2019
1	Hypotension (Low Blood Pressure) 01/2018
1	Median Arcuate Ligament Syndrome 12/2016
1	Fatigue 01/2016
1	Neutropenia 01/2016
1	Abdominal Abscess 01/2014
1	Cysts 11/2013
1	Fibrosis (Cirrhosis) 02/2013

Drug/Important Bio-Agent (IBA)

8	Gemcitabine FDA Link 02/2022 - 09/2010
5	Paclitaxel (Taxol)FDA LinkGeneric 03/2022 - 01/2017
3	Active Hexose Correlated CompoundIBA 02/2022 - 01/2016
3	CarbohydratesIBA 02/2022 - 04/2011
2	Immunologic Factors (Immunomodulators)IBA 02/2022 - 11/2021
2	130-nm albumin-bound paclitaxelIBA 02/2022 - 04/2021
2	AntigensIBA 07/2021 - 04/2011
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019 - 01/2016
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2019 - 01/2016
2	EnzymesIBA 03/2016 - 03/2014
2	Pancrelipase (Creon)FDA Link 03/2016 - 03/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2014 - 02/2013
2	A 19IBA 01/2014 - 08/2008
1	Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)IBA 02/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 10/2020
1	Serum AlbuminIBA 01/2020
1	Perilipin-2IBA 04/2019
1	CytokinesIBA 04/2019
1	Proteins (Proteins, Gene)FDA Link 04/2019
1	RNA (Ribonucleic Acid)IBA 04/2019
1	Indicators and Reagents (Reagents)IBA 04/2019
1	Amyloid (Amyloid Fibrils)IBA 01/2019
1	tau Proteins (tau Protein)IBA 01/2019
1	General AnestheticsIBA 01/2019
1	folfirinoxIBA 01/2019
1	Isoflurane FDA LinkGeneric 01/2018
1	TegafurIBA 01/2017
1	PotassiumIBA 01/2017
1	Tumor Biomarkers (Tumor Markers)IBA 09/2014
1	Angiotensin IIIBA 08/2014
1	Losartan (Cozaar)FDA LinkGeneric 08/2014
1	Angiotensin II Type 1 Receptor BlockersIBA 08/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2014
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2013
1	fascinIBA 04/2012
1	Biomarkers (Surrogate Marker)IBA 04/2011
1	Prostaglandins AIBA 01/2011
1	Polyglycolic Acid (Polyglycolide)IBA 01/2011
1	Fibrin Tissue Adhesive (Fibrin Sealant)IBA 01/2011
1	Peptides (Polypeptides)IBA 09/2010

Therapy/Procedure

14	Pancreatectomy 02/2022 - 12/2007
13	Drug Therapy (Chemotherapy) 06/2022 - 02/2013
10	Therapeutics 04/2021 - 09/2010
9	Pancreaticoduodenectomy 11/2022 - 01/2014
7	Adjuvant Chemotherapy 06/2022 - 01/2016
6	Neoadjuvant Therapy 02/2022 - 11/2010
3	Laparotomy 03/2022 - 04/2011
3	Cholecystectomy 01/2020 - 01/2019
2	Combined Modality Therapy 02/2022 - 05/2020
2	Operative Surgical Procedures 08/2021 - 01/2020
2	Pancreaticojejunostomy 01/2019 - 01/2011
2	Combination Drug Therapy (Combination Chemotherapy) 01/2019 - 01/2016
2	Length of Stay 01/2019 - 01/2014
2	Anesthesia 01/2019 - 01/2018
1	Jejunostomy 11/2022
1	Preoperative Period 11/2022
1	Gastrectomy 08/2021
1	Chemoradiotherapy 05/2020
1	Laparoscopic Cholecystectomy 01/2019
1	Hepatectomy 01/2018
1	General Anesthesia 01/2018
1	Blood Transfusion (Blood Transfusions) 01/2016
1	Aftercare (After-Treatment) 02/2013